Ingredient or product comparison
Clinical Evidence and Efficacy Comparison
GHK-Cu has the strongest standalone evidence base among cosmetic peptides. A 2012 double-blind placebo-controlled trial published in the Journal of Drugs in Dermatology evaluated 1% GHK-Cu cream applied twice daily for 12 weeks and found significant improvemen
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu has the strongest standalone evidence base among cosmetic peptides. A 2012 double-blind placebo-controlled trial published in the Journal of Drugs in Dermatology evaluated 1% GHK-Cu cream applied twice daily for 12 weeks and found significant improvements in skin laxity (27% reduction), wrinkle depth (18% average reduction), and collagen density measured via ultrasound. The mechanism was confirmed through skin biopsy analysis showing elevated collagen type I and III mRNA expression. A University of California study measured wound healing in diabetic rat models and found GHK-Cu accelerated re-epithelialization by 35%, attributed to increased vascular endothelial growth factor (VEGF).
- Glow Stack formulations lack equivalent standalone trial data because composition varies by manufacturer. However, individual peptides within these stacks have separate evidence profiles. Matrixyl demonstrated 18% improvement in wrinkle depth in a 2005 International Journal of Cosmetic Science trial. Acetyl hexapeptide-8 showed modest efficacy in reducing expression lines, with one manufacturer-funded study reporting 30% wrinkle depth reduction after 30 days. Growth hormone secretagogues like MK 677 have robust evidence for elevating IGF-1, but topical inclusion is uncommon.
- GHK-Cu has the strongest clinical backing as a standalone peptide for collagen synthesis and wound healing. Glow Stacks may provide broader anti-aging coverage when formulated correctly, but the evidence is compositional.